Skip to main content
. Author manuscript; available in PMC: 2022 Apr 16.
Published in final edited form as: Ann Surg Oncol. 2017 Aug 14;24(12):3494–3501. doi: 10.1245/s10434-017-6041-x

Table 1.

Clinical and pathologic characteristics

Surgery (n=105) Surgery+Adjuvant (n=105) Percent difference (95% CI)

Age (mean, STDEV) 63 (10.7) 61 (8.6) 2.5 (0.04 to 0.91)a

Gender
  Male 84 (80) 90 (86)
  Female 21 (20) 15 (14) 6 (−4 to 16)

Center
  1 47 (45) 46 (44)
  2 58 (55) 59 (56) −1 (−14 to 12)

Smoking
  No 63 (60) 46 (44)
  Yes 42 (40) 59 (56) −16 (−29 to −3)

ACE-27
  None 53 (53) 52 (50) 3 (−10 to 17)
  Mild 31 (31) 42 (40) −11 (−24 to 2)
  Moderate+Severe 16 (16) 11 (10) 6 (−14 to 12)

Subsite
  BOT 42 (40) 41 (39)
  Tonsil 62 (60) 64 (61) −1 (−14 to 12)

Treatment NA
  Surgery alone 105
  Adjuvant radiation 43 (41)
  Adjuvant chemoradiation 62 (59)

ECE
  No 81 (77) 35 (33)
  Yes 24 (23) 70 (67) −44 (−56 to 32)

PNI
  No 100 (95) 93 (89)
  Yes 5 (5) 12 (11) −6 (−13 to 1)

LVI
  No 93 (89) 85 (81)
  Yes 12 (11) 20 (19) −8 (−18 to 2)

Margins
  Negative 104 (99) 103 (98)
  Positive 1 (1) 2 (2) −1 (−4 to 2)

Pathologic T Stage NA
  1 and 2 90 (86) 90 (86)
  3 and 4 15 (14) 15 (14)

Lymph node NA
  <=4 100 (95) 100 (95)
  >4 5 (5) 5 (5)

Abbreviations: CI – Confidence interval; STDEV – Standard deviation; ACE-27 – Adult Comorbidity Evaluation-27; BOT – Base of tongue; ECE – Extracapsular extension; PNI – Perineural invasion; LVI – Lymphovascular invasion; NA – Not applicable

a

Mean difference and 95% CI